Page 2 - Les Meilleurs doctors pour votre Diagnostic oncologique complexe - TOP 33 des médecins

Education

Faculté de médecine : Faculté de médecine Sackler, Université de Tel Aviv

Spécialisation

Institut d'oncologie, Centre Davidoff, Hôpital Beilinson

Expérience reconnue

Oncologie médicale et radiothérapie

Département de radio-oncologie, Centre médical de l'Université Duke, États-Unis

• 2004-2005. - Stage à l'hôpital Beilinson.
• 2006-2012 - Stage en oncologie, Institut d'oncologie, Centre Davidoff, hôpital Beilinson.
• 2012-2017 - Médecin senior, chef du service de radiochirurgie et de radiothérapie des tumeurs nerveuses, Institut d'oncologie, Centre Davidoff, hôpital Beilinson.
• 2015-2016 - Formation avancée en radiochirurgie et radiothérapie des tumeurs cérébrales et cervicales, département de radiothérapie, centre médical de l'université Duke, États-Unis
• 2017 et plus - Directeur du service de radiothérapie des tumeurs du système nerveux, institut d'oncologie, centre médical de Tel-Aviv.

Participation à des conférences

Une quinzaine de publications professionnelles

Appartenance professionnelle

• Association israélienne d'oncologie et de radio-oncologie
• Association internationale de neuro-oncologie -. SNO
• Israël Neuro-Oncology Forum
• Israël Head and Neck Tumour Society

Domaines d'intérêt et d'occupation

Métastases cérébrales et tumeurs cérébrales primaires, Tumeurs de la tête et du cou, radiothérapie et radiochirurgie

.

• Est arrivée au terme de son internat en oncologie générale et radiothérapie à l'hôpital Sheba, Tel HaShomer.Au cours de son travail, elle a acquis une grande expérience dans le traitement des tumeurs de l'appareil génital féminin et est actuellement coordinatrice du traitement des patientes souffrant de ces maladies.
• Fellowship - Anderson Cancer Center, Houston, Texas - 2012-2014.

Les intérêts de recherche du Dr Tatiana Rabin: 

Méthodes de destruction des néoplasmes malins par chauffage aux ultrasons, étude de l'utilisation de la brachythérapie dans le traitement de l'oncologie gynécologique, 

étude des mécanismes de réponse au niveau moléculaire des cellules tumorales de la prostate à la radiothérapie; 

études cliniques de l'oncomammologie, de l'oncopulmonologie, du lymphome oculaire.Le Dr Rabin étudie les mécanismes moléculaires de la réponse des cellules tumorales de la prostate à la radiothérapie. Cette recherche est menée en collaboration avec le laboratoire de l'Institut Weizmann. 

Le Dr Rabin a également participé à des essais cliniques dans les domaines du cancer du sein, du cancer du poumon et du lymphome oculaire. 

Le Dr Rabin coordonne actuellement une nouvelle étude unique menée à l'hôpital Sheba pour étudier une méthode de traitement des tumeurs cancéreuses à l'aide d'ondes ultrasonores guidées par l'IRM. Cette méthode consiste à augmenter la température de la tumeur jusqu'à une certaine limite, puis à la détruire.

Récompenses: 

Le Dr Tatiana Rabin a été nommée meilleure employée de l'hôpital en 2007. 

Expérience et implication dans la recherche : 

• • Recherche dans le domaine de l'oncogynécologie 
  • Recherche dans le domaine des tumeurs pulmonaires 
  • Application de la brachiothérapie en oncogynécologie 
  • Techniques de SRB dans le traitement des tumeurs du système respiratoire 
  • Recherche sur les mécanismes moléculaires de la réponse des cellules tumorales de la prostate à la radiothérapie. Cette recherche est organisée en collaboration avec le laboratoire de l'Institut Weizmann. 
  • Le Dr Rabin a également participé à des essais cliniques dans les domaines du cancer du sein, du cancer du poumon et du lymphome de l'œil.Membre de sociétés médicales: 
    • Israeli Association for Cancer and Clinical Radiotherapy (ISCORT) American Association of Radiology and Oncology (ASTRO) 
    • Israeli Association for Palliative Care 

Dr. Herishanu Yair is a hematologist with 25 years of experience. He specializes in chronic lymphocytic leukemia (CLL). He is skilled in bone marrow transplantation, immunotherapy, CAR T-cell therapy, and leukemia chemotherapy.

Dr. Herishanu has received several awards, including the Young Investigator Research Prize, Clinical Excellence Prize, and Klitzberg Oncology Award. He has made important contributions to CLL research. His work includes many published studies and research grants from leading institutions.

He is a member of the Israeli and American Hematology Associations. This highlights his expertise and dedication to the field of hematology.

Médecin-chef du Centre d'Oncologie , Oncologue

Dr. Tolga Akman is a urologist with expertise in advanced surgical procedures. He performs penis prosthesis, bladder, prostate, and kidney cancer surgeries. He is skilled in laparoscopic urology and kidney stone treatments. Dr. Akman also treats female urinary incontinence, pediatric vesicoureteral reflux, and performs microsurgical varicocele procedures. He offers penis enlargement and correction of Peyronie’s disease.

Dr. Akman completed his residencies at Istanbul University School of Medicine and Bezmialem Vakıf University. He is now a Professor of Medicine at Medicana Hospital Bahcelievler. He is active in both clinical practice and academic work in urology.

Dr. Ahmer Arif Shaikh, MDS (Oral & Maxillofacial Surgery), is a specialist in Surgical Oncology. He has 3 years of experience at HCG Manavata Cancer Centre, Nashik. He focuses on oral cancer treatment, organ preservation, and functional rehabilitation for oral cancer patients.

Dr. Shaikh has completed a Fellowship in Head & Neck Surgical Oncology. He is skilled in complex maxillofacial and head & neck surgeries. He is also an active researcher with several publications in reputed journals. His work shows a strong commitment to improving cancer care.

Dr. Lalit Banswal is an experienced oncological surgeon with 10 years in the field. He has performed more than 10,000 major surgeries. He earned his MBBS from MIMER, Pune, and completed his MS at GMC Panaji. He also completed a fellowship in Surgical Oncology at Tata Medical Centre, Kolkata, with a focus on gastrointestinal cancers.

Dr. Banswal has worked as a Co-principal Investigator in several research projects. He has published his work in both national and international journals. He is known for his patient-friendly and ethical approach. His main expertise is in Minimal Invasive Cancer Surgeries, where he consistently delivers excellent results.

Dr. Shaunak Valame is an MD in Internal Medicine and holds a DNB in Medical Oncology. He received advanced training at Indraprastha Apollo Hospital in New Delhi. He also worked as a Registrar at Jawaharlal Nehru Cancer Hospital in Bhopal. Dr. Valame has presented his research at international forums, including the Gastrointestinal Cancer Symposium in San Francisco.

He is known for his work in targeted cancer therapies. He has given lectures at the International Winter School of Oncology at AIIMS Bhopal. Dr. Valame is accredited by the American Society of Clinical Oncology. He is committed to advancing cancer research and clinical care.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.

Dr. Antonio Cubillo Gracián is a specialist in Medical Oncology. He has broad teaching and clinical experience at USP CEU and HM CIOCC. He has directed postgraduate research as Director of the Master’s in Clinical and Applied Research in Oncology. Since 2009, he has tutored more than 100 students, residents, and rotating staff.

Dr. Cubillo has advanced oncology education by teaching subjects such as General Medical Pathology, Oncology, Bioethics, and Pathophysiology. He has organized international courses on digestive neoplasms. He has also worked with leading institutions, including MD Anderson Cancer Center. His academic leadership and clinical mentorship have set high standards in oncology training and research.